Idexx Laboratories IDXX Return on equity
Return on equity at other companies
Other financials
Where this comes from
Calculated from Idexx Laboratories’s reported figures.
Based on trailing twelve months.
The official record: Idexx Laboratories’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Idexx Laboratories's return on equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Idexx Laboratories's return on equity?
- Idexx Laboratories (IDXX) reported return on equity of 72.9% in Q1 2026.
- How has Idexx Laboratories's return on equity changed year-over-year?
- Idexx Laboratories's return on equity increased by 22.9% year-over-year, from 59.3% to 72.9%.
- What is the long-term trend for Idexx Laboratories's return on equity?
- Over 4 years (2021 to 2025), Idexx Laboratories's return on equity has grown at a -17.4% compound annual growth rate (CAGR), from 548.4% to 255%.
- What does return on equity mean?
- How much profit the company earns on the money shareholders have invested.
- How do you interpret return on equity?
- Higher is better, but very high ROE can be manufactured by leverage — a thin equity base inflates the ratio. Read it next to debt-to-equity and ROIC to tell genuine returns from balance-sheet engineering.
- How does return on equity compare across companies?
- Comparable across peers, with the leverage caveat. Negative or near-zero equity makes ROE meaningless, so it is suppressed there.